What does the FDA reclass of Rapid Influenza Diagnostic Tests mean for you?
From lateral flow to molecular testing, we have a solution that will ensure FDA compliance
Need more information?
Complete this form if you would like information on Cardinal Health’s portfolio of influenza testing platforms that address a variety of needs and will ensure FDA compliance.
Influenza testing platforms
With the new guidelines and controls in place, Cardinal Health is well-positioned to meet the newly updated FDA reclassification requirements and provide you with a portfolio of influenza testing platforms that address a variety of needs.
From lateral flow to molecular testing, we have a solution that will ensure FDA compliance.
Solana®
Molecular
Moderately complex – No culture backup required for Strep A
Influenza A & B
Strep A Complete (Strep pyogenes and pyogenic Group C/G)
Strep A (Strep pyogenes)
HSV 1 & 2/VZV
C difficile
Trichomonas (swab and urine – separate kits)
Sofia®2
Reader based rapid test
Waived
Status Flu A & B
Lateral flow test
Waived